Kazelnut develops state-of-the-art approaches to metabolic health and wellness

What is the initial pilot study design?

The pilot study is comprised of health individuals between 19 and 60 years of age with BMIs that range between 20 and 35 kg/m2. Collected blood, plasma, urine and saliva samples will undergo multiomics testing including mass spectrometry and next generation sequencing. The resulting data will be analyzed using novel biostatistical methods and employing machine learning to identify genomic, proteomic and transcriptomic profiles of healthy adults.